aundice results from high levels of bilirubin in the blood. Bilirubin is the normal breakdown product from the catabolism of haem, and thus is formed from the destruction of red blood cells.
Under normal circumstances, bilirubin undergoes conjugation within the liver, making it water-soluble. It is then excreted via the bile into the GI tract, the majority of which is egested in the faeces as urobilinogen and stercobilin (the metabolic breakdown product of urobilingoen). Around 10% of urobilinogen is reabsorbed into the bloodstream and excreted through the kidneys. Jaundice occurs when this pathway is disrupted.
Types of Jaundice
There are three main types of jaundice: pre-hepatic, hepatocellular, and post-hepatic.
In pre-hepatic jaundice, there is excessive red cell breakdown which overwhelms the liver’s ability to conjugate bilirubin. This causes an unconjugated hyperbilirubinaemia.
Any bilirubin that manages to become conjugated will be excreted normally, yet it is the unconjugated bilirubin that remains in the blood stream to cause the jaundice.
In hepatocellular (or intrahepatic) jaundice, there is dysfunction of the hepatic cells. The liver loses the ability to conjugate bilirubin, but in cases where it also may become cirrhotic, it compresses the intra-hepatic portions of the biliary tree to cause a degree of obstruction.
This leads to both unconjugated and conjugated bilirubin in the blood, termed a ‘mixed picture’.
Post-hepatic jaundice refers to obstruction of biliary drainage. The bilirubin that is not excreted will have been conjugated by the liver, hence the result is a conjugated hyperbilirubinaemia.
Any patient presenting with jaundice should have the following bloods taken:
- Liver function tests (LFTs), as summarised in Table 2
- Coagulation studies (PT can be used as a marker of liver synthesis function)
- FBC (anaemia, raised MCV, and thrombocytopenia all seen in liver disease) and U&Es
- Specialist blood tests, as summarised below as part of a liver screen
|Bilirubin||Quantify degree of any suspected jaundice|
|Albumin||Marker of liver synthesising function|
|AST and ALT||Markers of hepatocellular injury*|
|Alkaline Phosphatase||Raised in biliary obstruction (as well as bone disease, during pregnancy, and certain malignancies)|
|Gamma-GT||More specific for biliary obstruction than ALP (however not routinely performed)|
Table 2 – LFT serum markers. *as an estimate, if the AST:ALT ratio >2, this is likely alcoholic liver disease, whilst if AST:ALT is around 1, then likely viral hepatitis as the cause
A liver screen can be performed for patients whereby there is no initial cause for liver dysfunction, tailored to whether acute or chronic liver failure
|Viral Serology||Non-Infective Markers|
|Acute Liver Injury||Hepatitis A, Hepatitis B, Hepatitis C, and Hepatitis ECMV and EBV||Paracetamol levelCaeruloplasminAntinuclear antibody and IgG subtypes|
|Chronic Liver Injury||Hepatitis BHepatitis C||CaeruloplasminFerritin and transferrin saturationTissue Transglutaminase antibodyAlpha-1 antitrypsinAutoantibodies*|
Table 3 – Acute and Chronic Liver Screens *Autoantibodies include anti-mitochondrial antibody (AMA), anti-smooth-muscle antibody (Anti-SMA), and anti-nuclear antibody (ANA), used to identify a variety of autoimmune liver conditions, such as primary sclerosing cholangitis (PSC)
The imaging used will depend on the presumed aetiology. An ultrasound abdomen is usually first line, identifying any obstructive pathology present or gross liver pathology (albeit often user dependent).
Magnetic Resonance Cholangiopancreatography (MRCP) is used to visual the biliary tree, typically performed if the jaundice is obstructive, but US abdomen was inconclusive or limited, or as further work-up for surgical intervention.
A liver biopsy can be performed when the diagnosis has not been made despite the above investigations.
The definitive treatment of jaundice will be dependent on the underlying cause. Obstructive causes may require removal of a gallstone through Endoscopic Retrograde CholangioPancreatography (ERCP) or stenting of the common bile duct.
Symptomatic treatment is often needed for the itching caused by hyperbilirubinaemia. An obstructive cause may warrant cholestyramine (acting to increase biliary drainage), whilst other causes may respond to simple anti-histamines.
Identify and manage any complications where possible. Monitor for coagulopathy, treating promptly (either vitamin K or fresh frozen plasma (FFP) is needed) if any evidence of bleeding or rapid coagulopathy, and treat hypoglycaemia orally if possible (otherwise 5% dextrose is needed).
|Haemolytic anaemiaGilbert’s syndromeCriggler-Najjar syndrome||Alcoholic liver diseaseViral hepatitisIatrogenic, e.g. medicationHereditary haemochromatosisAutoimmune hepatitisPrimary biliary cirrhosis or primary sclerosing cholangitisHepatocellular carcinoma||Intra-luminal causes, such as gallstonesMural causes, such as cholangiocarcinoma, strictures, or drug-induced cholestasisExtra-mural causes, such as pancreatic cancer or abdominal masses (e.g. lymphomas)|
Table 1 – Potential Causes for Jaundice, divided into pre-hepatic, hepatocellular, and post-hepatic
Discussion about this post